All Type (Wound Treatment)

Clinical Summary: Wound treatment dressings are classified medical devices used to manage acute and chronic wounds by providing a moist healing environment, controlling exudate, preventing infection, and promoting tissue regeneration. Selection is guided by wound type, depth, exudate level, infection status, and patient factors, with product categories including hydrocolloid, alginate, foam, film, hydrogel, antimicrobial silver, and collagen dressings. In Singapore, procurement for hospitals and community clinics follows HSA Class B/C medical device registration requirements, and all products listed in this collection are CE-marked and/or FDA-cleared under 21 CFR Part 880.

Wound Treatment Dressings: Buyer's Guide for Singapore Healthcare Professionals

Selecting the appropriate wound dressing is a critical clinical decision that directly affects healing trajectories, patient comfort, and cost of care. Modern wound management has moved beyond simple gauze coverage to evidence-based dressing selection matched to wound characteristics. This guide covers the principal dressing categories available through EMIS+, their mechanisms, clinical indications, and procurement considerations for Singapore healthcare facilities.

Singapore's wound care market is driven by an ageing population with elevated prevalence of diabetes mellitus (approximately 9.5% prevalence, Singapore National Population Health Survey), pressure injuries in long-term care, and post-surgical wound management. The Ministry of Health Singapore's Clinical Practice Guidelines and the Singapore Wound Care Guidelines (SWCG) provide the framework for evidence-based product selection.

Dressing Categories and Clinical Indications

Dressing Type Mechanism Primary Indications Exudate Level Change Frequency
Hydrocolloid Absorbs exudate and forms a gel; maintains moist wound environment Pressure ulcers stage I–II, minor burns, superficial abrasions Low–moderate 3–7 days
Alginate / Silver Alginate High-G alginate fibres absorb up to 20× their weight; silver ions provide sustained antimicrobial activity Infected wounds, diabetic foot ulcers, venous leg ulcers, cavity wounds Moderate–heavy 1–3 days
Foam Polyurethane foam absorbs and retains exudate; thermal insulation protects wound bed Pressure injuries, exuding surgical wounds, skin tears Moderate–heavy 2–5 days
Hydrogel Donates moisture to dry wound beds; facilitates autolytic debridement Necrotic wounds, radiation injuries, dry sloughy wounds Nil–low 1–3 days
Transparent Film Semi-permeable membrane allows gas exchange; waterproof barrier prevents contamination IV site protection, superficial wounds, secondary dressing, blister management Nil–minimal Up to 7 days
Collagen Provides collagen matrix scaffold; sequesters proteases that impair healing in chronic wounds Chronic non-healing wounds, stalled wounds, partial-thickness burns Low–moderate 2–7 days
NPWT (Negative Pressure) Applies sub-atmospheric pressure to promote granulation tissue formation and remove exudate Complex surgical wounds, open abdominal wounds, large traumatic wounds, graft preparation Heavy 48–72 hours per canister

Clinical Dressing Selection Criteria

  • Wound aetiology: Diabetic foot ulcers, pressure injuries, venous/arterial ulcers, traumatic, surgical, and oncological wounds each have distinct management pathways. Compression therapy is indicated concurrently for venous ulcers (Ankle-Brachial Pressure Index ≥0.8) per EWMA 2014 guidelines.
  • Wound bed preparation (WBP): Apply the TIME framework (Tissue, Infection/Inflammation, Moisture balance, Edge advancement) to guide dressing category selection at each patient review.
  • Exudate volume and viscosity: High-exudate wounds require high-absorbency dressings (alginate, foam, hydrofibre) to prevent maceration of periwound skin; dry wounds require hydration (hydrogel or saline-dampened gauze).
  • Infection indicators: Localised signs (increased pain, warmth, erythema, purulent exudate) or critical colonisation (delayed healing, friable granulation) indicate silver or antimicrobial dressings; systemic infection requires concurrent systemic antibiotics per MOH antimicrobial stewardship guidelines.
  • Patient/setting factors: Adhesive tolerance, frequency of dressing change capacity (community vs. inpatient), dressing cost over the wound episode, and HSA-registered product status for institutional formulary compliance.
  • Regulatory compliance: All dressings for clinical use in Singapore must be registered with the Health Sciences Authority (HSA) as Class B or C medical devices under the Health Products Act (HPA) Chapter 122D; CE MDR 2017/745 or FDA 510(k) clearance under 21 CFR 880.5900 supports HSA registration.

Frequently Asked Questions

Q: How do I select between an alginate and a foam dressing for a heavily exuding wound?
A: Alginate dressings (particularly calcium alginate or silver-calcium alginate) are preferred when the wound is infected or at risk of infection due to their sustained silver ion release and high fluid-handling capacity. Foam dressings are preferred when the wound is clinically clean with heavy exudate, as they provide better exudate retention and patient comfort over longer wear times. Per EWMA clinical guidelines, the two categories can be used in combination — alginate as a primary contact layer, foam as a secondary absorbent layer.

Q: Are these dressings suitable for use on diabetic foot ulcers in Singapore?
A: Yes. Diabetic foot ulcer management in Singapore follows the MOH Clinical Practice Guidelines for Diabetes Mellitus (CPG DM 2014, revised 2023) and the Singapore Diabetic Foot Protocol. Silver alginate and foam dressings are first-line options for infected and heavily exuding diabetic foot wounds respectively. NPWT is indicated for post-debridement wounds and is reimbursable under Medisave for approved indications at MOH-licensed facilities.

Q: What regulatory documentation should I request from my supplier in Singapore?
A: Request: (1) HSA medical device registration certificate (Class B or C), (2) CE Certificate of Conformity under MDR 2017/745 or MDD 93/42/EEC (transitional), (3) ISO 13485:2016 quality management system certificate for the manufacturer, (4) ISO 10993 biocompatibility test report, and (5) sterilisation validation per ISO 11137. EMIS+ supplies all documentation on request for institutional tender submission.

Q: Can advanced wound dressings be claimed under Medisave in Singapore?
A: Advanced wound dressings are not directly claimable under Medisave; however, the wound management consultation and procedure costs at licensed outpatient facilities may qualify. NPWT devices and consumables used in MOH-licensed hospitals are subject to itemised billing. Patients under the Community Health Assist Scheme (CHAS) may access subsidised wound care at participating general practitioners and polyclinics.

Q: How should wound dressings be stored and disposed of?
A: Most sterile wound dressings should be stored at 15–25°C, away from moisture and direct sunlight, with packaging integrity inspected before each use. Single-use dressings must not be reprocessed. Used dressings with exudate should be disposed of as clinical waste (Category 2 under Singapore NEA Infectious Waste guidelines) in yellow biohazard bags at licensed clinical facilities.